Citation Impact
Citing Papers
Prospective identification of tumorigenic breast cancer cells
2003 Standout
Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
2011
Colorectal cancer statistics, 2023
2023 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
2012
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine
1993
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer
2000
MYC on the Path to Cancer
2012 Standout
A view on drug resistance in cancer
2019 StandoutNature
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
1994 Standout
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Hypocomplementemia Discloses Genetic Predisposition to Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura
1999
Chemotherapy for malignant gliomas
1988
Aromatase Inhibitors in Breast Cancer
2003
Phase III Multi-Institutional Trial of Adjuvant Chemotherapy With Paclitaxel, Estramustine, and Oral Etoposide Combined With Long-Term Androgen Suppression Therapy and Radiotherapy Versus Long-Term Androgen Suppression Plus Radiotherapy Alone for High-Risk Prostate Cancer: Preliminary Toxicity Analysis of RTOG 99-02
2008
Vincristine hyperalgesia in the rat: A model of painful vincristine neuropathy in humans
1996
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Ovarian cancer
2014 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Neurologic disorders in patients with small cell lung cancer
1987
Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat
1990
AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies
2008
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
1990 Standout
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Paclitaxel (Taxol)
1995 Standout
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
2001 Standout
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
2011
Colorectal cancer
2013 Standout
Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program.
1993
Vincristine revisited
1999
Antitumour actions of interferons: implications for cancer therapy
2016
Amelioration of Experimental Cisplatin and Paclitaxel Neuropathy with Glutamate
1999
Colorectal cancer
2019 Standout
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy
2004
Nanomedicine
2006
Endocrine Therapies for Patients with Recurrent Breast Cancer: Predictive Factors for Responses to First- and Second-Line Endocrine Therapies
2000
Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer
1997
Polymer Conjugates
1994
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation
2002 Standout
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy
2011
Chemotherapy as treatment of primary and recurrent small cell lung cancer
2001
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
2011 Standout
A Model to Select Chemotherapy Regimens for Phase III Trials for Extensive-Stage Small-Cell Lung Cancer
2000
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
ACUTE MYELOID LEUKAEMIA IN THE ELDERLY: BIOLOGY AND TREATMENT
1993
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
2012 Standout
Complement
2001 Standout
The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy.
1987
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy
1997 Standout
Microtubules as a target for anticancer drugs
2004 Standout
Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer
2008
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Mechanisms of Bone Metastasis
2004 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
HLA‐DR53 protects against thrombotic thrombocytopenic purpura/adult hemolytic uremic syndrome
1994
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.
1995
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
2004 Standout
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Patterns of Colorectal Cancer Care in the United States: 1990–2010
2015
Chemotherapy of Metastatic Breast Cancer in the Elderly
1992
Phase I Study of Liposomal Vincristine
1999
Radation therapy for brain metastases
1980
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Cancer of the Breast
1980
Chemotherapy of brain metastases: Current status
1984
Locoregional Recurrence Patterns After Mastectomy and Doxorubicin-Based Chemotherapy: Implications for Postoperative Irradiation
2000
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
2007
Progress and controversies: Radiation therapy for invasive breast cancer
2013
Polymeric Systems for Controlled Drug Release
1999 Standout
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients
2006
Scoliosis and Fractures in Young Ballet Dancers
1986 Standout
Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell Death
1999
Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization.
2004
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Irinotecan Fluorouracil Plus Leucovorin Is Not Superior to Fluorouracil Plus Leucovorin Alone As Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803
2007
A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma.
1985
The importance of dose intensity in chemotherapy of metastatic breast cancer.
1984 Standout
Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
2009
Pharmacokinetics of vincristine in cancer patients treated with nifedipine
1989
Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.
1984
Cancer, Clinical Pharmacology, and Aging
1987
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (intron a)
1986
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The Chemistry of Neutron Capture Therapy
1998 Standout
Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.
1989
A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer
1983
Does Locoregional Radiation Therapy Improve Survival in Breast Cancer? A Meta-Analysis
2000
The Anthracycline Antineoplastic Drugs
1981 Standout
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia
2006
Plasma pharmacokinetics of vinblastine and the investigational Vinca alkaloid N-(deacetyl-O-4-vinblastoyl-23)-L-ethyl isoleucinate in mice as determined by high-performance liquid chromatography.
1993
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
The therapeutic value of poly(ethylene glycol)-modified proteins
1991
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
1992 StandoutScience
Works of Don V. Jackson being referenced
Improvement of long-term survival in extensive small-cell lung cancer.
1988
Phase II Randomized Trial of Weekly Paclitaxel with or Without Estramustine Phosphate in Progressive, Metastatic, Hormone-Refractory Prostate Cancer
2004
High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.
1990
A phase II trial of peg-L-asparaginase in the treatment of non-hodgkins lymphoma
1990
A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer
1991
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study.
1994
Amelioration of vincristine neurotoxicity by glutamic acid
1988
Lack of potentiation of vincristine-induced neurotoxicity by VP-16–213
1983
A phase II study of recombinant alpha interferon in patients with recurrent or metastatic breast cancer.
1984
A randomized comparative trial of chemotherapy and irradiation therapy for stage ii breast cancer
1981
Moderate-Dose Vincristine Infusion in Refractory Breast Cancer
1986
Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089
2005
Clinical trial of folinic acid to reduce vincristine neurotoxicity
1986
Pharmacokinetics of vincristine sulfate in adult cancer patients.
1981
Clinical trial of pyridoxine to reduce vincristine neurotoxicity
1986
A sensitive radioimmunoassay for vincristine and vinblastine
1980
Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion
1984
Biliary excretion of vincristine
1978
High-dose cyclophosphamide and 5-fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast: A phase III study of the piedmont oncology association (POA)
1984
Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer. A randomized trial
1978
Single agent vincristine by infusion in refractory multiple myeloma.
1985
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
1988
Trifluoperazine Reversal of Secretory Diarrhea in Pancreatic Cholera
1980
Prophylactic Cranial Irradiation in Small Cell Carcinoma of the Lung
1977
Intravenous vincristine infusion: Phase I trial
1981
Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of bacillus calmette-guerin (MER) in advanced breast cancer: A randomized trial by the piedmont oncology association
1981
Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer. A randomized trial of the piedmont oncology association
1982
Pharmacokinetics of vincristine in the cerebrospinal fluid of humans.
1981
Recombinant gamma interferon in advanced breast cancer: A phase II trial
1986
Improved tolerance of vincristine by glutamic acid
1984
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: A randomized trial
1981
Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates.
1980
Low-dose ara-C therapy for acute myelogenous leukemia in elderly patients.
1989
Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro.
1979